Analysis of Bone Phenotype Differences in MEN1-Related and Sporadic Primary Hyperparathyroidism Using 3D-DXA
<b>Background:</b> The rarity and variability of MEN1-related primary hyperparathyroidism (mPHPT) has led to contradictory data regarding the bone phenotype in this patient population. <b>Methods:</b> A single-center retrospective study was conducted among young age- and sex-matched patients with mPHPT and sporadic hyperparathyroidism (sPHPT). The main parameters of calcium-phosphorus metabolism, bone remodeling markers, and bone mineral density (BMD) measurements were obtained during the active phase of hyperparathyroidism before parathyroidectomy (PTE) and 1 year after. Trabecular Bone Score (TBS) and 3D-DXA analysis of the proximal femur were used to evaluate the differences in bone architecture disruption between groups. <b>Results:</b> Patients with mPHPT had significant lower preoperative BMD compared to sPHPT at lumbar spine-LS (<i>p</i> = 0.002); femur neck-FN (<i>p</i> = 0.001); and total hip-TH (<i>p</i> = 0.002). 3D-DXA analysis showed the prevalence of cortical rather than trabecular bone damage in mPHPT compared to sPHPT: cortical thickness (<i>p</i> < 0.001); cortical surface BMD (<i>p</i> = 0.001); cortical volumetric BMD (<i>p</i> = 0.007); and trabecular volumetric BMD (<i>p</i> = 0.029). One year after, PTE DXA and 3D-DXA parameters were similar between groups, while 3D-visualisation showed more extensive regeneration in cortical sBMD and cortical thickness in mPHPT. <b>Conclusions:</b> mPHPT is associated with lower preoperative BMD values with predominant architecture disruption in the cortical bone. The absence of differences in DXA and 3D-DXA parameters 1 year after PTE between mPHPT/sPHPT combined with significantly lower BMD in mPHPT at the initial stage may indicate faster bone recovery after surgery in mPHPT than in sPHPT.
Authors
- Anna Eremkina (ORCID: https://orcid.org/0000-0001-6667-062X)
- Svetlana V. Pylina (ORCID: https://orcid.org/0000-0002-4920-2143)
- Н. В. Тарбаева (ORCID: https://orcid.org/0000-0001-7965-9454)
- Ekaterina Solodovnikova (ORCID: https://orcid.org/0000-0002-2406-9016)
- A. R. Elfimova (ORCID: https://orcid.org/0000-0001-6935-3187)
- Ekaterina A. Vetchinkina (ORCID: https://orcid.org/0000-0001-8069-5540)
- Mirella López Picazo (ORCID: https://orcid.org/0000-0001-7578-6704)
- А. М. Горбачева (ORCID: https://orcid.org/0000-0003-2669-9457)
- E. V. Bondarenko (ORCID: https://orcid.org/0000-0003-2122-2297)
- Ludovic Humbert (ORCID: https://orcid.org/0000-0002-3675-7908)
- L. D. Kovalevich (ORCID: https://orcid.org/0000-0001-8958-8223)
- Natalia G. Mokrysheva
- Angelina V. Hajrieva
Institutions
- Endocrinology Research Center (RU)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2024-10-25
- DOI
- https://doi.org/10.3390/jcm13216382
- Citations
- 4
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Ministry of Science and Higher Education of the Russian Federation